Company profile
CMTx Biotech, Inc.
Commercializing proprietary, non-antibiotic, chemically-modified tetracycline (CMT) compositions and formulations.
- Industry
- Biotechnology
- Employees
- 6
- Headquarters
- Stony Brook, New York
- Founded
- 2019
- LinkedIn followers
- 1,439
- Office locations
- 1
CMTx Biotech, Inc. company summary
CMTx Biotech, Inc. is a company in the Biotechnology industry, headquartered in Stony Brook, New York, founded in 2019. On LinkedIn the company has around 6 employees and 1,439 followers.
What technology does CMTx Biotech, Inc. use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About CMTx Biotech, Inc.
CMTx Biotech is commercializing a pipeline of proprietary, non-antibiotic, chemically-modified tetracycline (CMT) compositions and formulations for the host-modulatory treatment of diseases with high unmet needs. The company’s lead drug candidate is a clinical-stage, orally-administered small molecule (incyclinide / CMT-3 / COL-3) for the treatment of hospitalized sepsis patients at risk of septic shock, multiple organ dysfunction syndrome (MODS) and acute respiratory distress syndrome (ARDS), including from SARS-CoV-2 infection (COVID-19) and other infectious diseases. Our clinical-stage drug candidate has already demonstrated impressive efficacy in a number of animal models of sepsis/ARDS/MODS across multiple species (rats, mice, pigs, sheep). It has also been evaluated in over 450 patients across eleven Phase I/II clinical studies, which showed that the drug is well-tolerated. CMTx Biotech also has a pipeline of pre-clinical stage analogues for the treatment of diseases with high unmet need.
Where is CMTx Biotech, Inc. located?
CMTx Biotech, Inc. lists 1 location.
Compare companies similar to CMTx Biotech, Inc.
More companies in Biotechnology.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
CMTx Biotech, Inc. cmtxbiotech.com | Biotechnology | 6 | 2019 | Stony Brook, New York |
 Regeneron regeneron.com | Biotechnology | 17,234 | - | Tarrytown, New York |
 Bharat Biotech bharatbiotech.com | Biotechnology | 2,035 | 1996 | Hyderabad, Telangana |
 Enzene Biosciences Ltd enzene.com | Biotechnology | 1,023 | 2008 | Pune, Maharashtra |
| Biotechnology | 393 | - | Bethesda, MD | |
 LifeCell International Pvt.Ltd lifecell.in | Biotechnology | 2,650 | 2004 | Chennai, India |
 TMG - Tropical Melhoramento & Genética tmg.agr.br | Biotechnology | 692 | 2001 | Cambé, PR |
 Organica Biotech organicabiotech.com | Biotechnology | 146 | 2000 | Mumbai, Maharashtra |
 Allogene Therapeutics allogene.com | Biotechnology | 217 | 2017 | South San Francisco, California |
 Labtest Diagnóstica S.A. labtest.com.br | Biotechnology | 227 | 1971 | Lagoa Santa, Minas Gerais |
 Orchard Therapeutics - U.S. orchard-tx.com | Biotechnology | 243 | 2015 | London, United Kingdom |
Frequently asked questions about CMTx Biotech, Inc.
What does CMTx Biotech, Inc. do?
CMTx Biotech is commercializing a pipeline of proprietary, non-antibiotic, chemically-modified tetracycline (CMT) compositions and formulations for the host-modulatory treatment of diseases with high unmet needs. The company’s lead drug candidate is a clinical-stage, orally-administered small molecule (incyclinide / CMT-3 / COL-3) for the treatment of hospitalized sepsis patients at risk of septic shock, multiple organ dysfunction syndrome (MODS) and acute respiratory distress syndrome (ARDS), including from SARS-CoV-2 infection (COVID-19) and other infectious diseases. Our clinical-stage drug candidate has already demonstrated impressive efficacy in a number of animal models of sepsis/ARDS/MODS across multiple species (rats, mice, pigs, sheep). It has also been evaluated in over 450 patients across eleven Phase I/II clinical studies, which showed that the drug is well-tolerated. CMTx Biotech also has a pipeline of pre-clinical stage analogues for the treatment of diseases with high unmet need.
How many employees does CMTx Biotech, Inc. have?
CMTx Biotech, Inc. has around 6 employees on LinkedIn.
Where is CMTx Biotech, Inc. headquartered?
CMTx Biotech, Inc. is headquartered in Stony Brook, New York.
When was CMTx Biotech, Inc. founded?
CMTx Biotech, Inc. was founded in 2019.
Build a lead list from companies like CMTx Biotech, Inc.
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.